Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Inventory Average (2016 - 2025)

IGC Pharma (IGC) has disclosed Inventory Average for 14 consecutive years, with $703500.0 as the latest value for Q2 2025.

  • On a quarterly basis, Inventory Average rose 1266.02% to $703500.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $703500.0, a 1266.02% increase, with the full-year FY2025 number at $706000.0, up 1757.89% from a year prior.
  • Inventory Average was $703500.0 for Q2 2025 at IGC Pharma, roughly flat from $701500.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $3.4 million in Q1 2021 to a low of $19500.0 in Q2 2023.
  • A 5-year average of $597307.7 and a median of $325000.0 in 2022 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: crashed 96.42% in 2024, then skyrocketed 1266.02% in 2025.
  • IGC Pharma's Inventory Average stood at $3.4 million in 2021, then tumbled by 96.94% to $105000.0 in 2022, then surged by 1162.38% to $1.3 million in 2023, then plummeted by 96.72% to $43500.0 in 2024, then surged by 1517.24% to $703500.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Inventory Average are $703500.0 (Q2 2025), $701500.0 (Q1 2025), and $43500.0 (Q4 2024).